Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?
PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.
Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.
Multiple sclerosis in 2014: Progress in MS-classification, mechanisms and treatment.
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
Comparative effectiveness of early Natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis.
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
Erratum to: Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
Genpharm and Genzyme Aubagio ® agreement for the MENA region
Multiple sclerosis: clinical presentation, diagnosis and treatment.
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.
Biogen Idec and AbbVie announce positive top-line results from Phase 3 study investigating daclizumab high-yield process in multiple sclerosis
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.
Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.

Pages